Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Cancer (Tumor) Profiling Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Cancer (Tumor) Profiling Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Immunoassay
      • 1.3.3 Hybridization
      • 1.3.4 NGS
      • 1.3.5 Mass Spectrometry
    • 1.4 Market Segment by Application
      • 1.4.1 Global Cancer (Tumor) Profiling Market Share by Application (2019-2025)
      • 1.4.2 Clinical
      • 1.4.3 Research
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Cancer (Tumor) Profiling Market Size
      • 2.1.1 Global Cancer (Tumor) Profiling Revenue 2014-2025
      • 2.1.2 Global Cancer (Tumor) Profiling Sales 2014-2025
    • 2.2 Cancer (Tumor) Profiling Growth Rate by Regions
      • 2.2.1 Global Cancer (Tumor) Profiling Sales by Regions 2014-2019
      • 2.2.2 Global Cancer (Tumor) Profiling Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Cancer (Tumor) Profiling Sales by Manufacturers
      • 3.1.1 Cancer (Tumor) Profiling Sales by Manufacturers 2014-2019
      • 3.1.2 Cancer (Tumor) Profiling Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Cancer (Tumor) Profiling Revenue by Manufacturers (2014-2019)
      • 3.2.2 Cancer (Tumor) Profiling Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Cancer (Tumor) Profiling Market Concentration Ratio (CR5 and HHI)
    • 3.3 Cancer (Tumor) Profiling Price by Manufacturers
    • 3.4 Key Manufacturers Cancer (Tumor) Profiling Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Cancer (Tumor) Profiling Market
    • 3.6 Key Manufacturers Cancer (Tumor) Profiling Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 Immunoassay Sales and Revenue (2014-2019)
      • 4.1.2 Hybridization Sales and Revenue (2014-2019)
      • 4.1.3 NGS Sales and Revenue (2014-2019)
      • 4.1.4 Mass Spectrometry Sales and Revenue (2014-2019)
    • 4.2 Global Cancer (Tumor) Profiling Sales Market Share by Type
    • 4.3 Global Cancer (Tumor) Profiling Revenue Market Share by Type
    • 4.4 Cancer (Tumor) Profiling Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Cancer (Tumor) Profiling Sales by Application

    6 United States

    • 6.1 United States Cancer (Tumor) Profiling Breakdown Data by Company
    • 6.2 United States Cancer (Tumor) Profiling Breakdown Data by Type
    • 6.3 United States Cancer (Tumor) Profiling Breakdown Data by Application

    7 European Union

    • 7.1 European Union Cancer (Tumor) Profiling Breakdown Data by Company
    • 7.2 European Union Cancer (Tumor) Profiling Breakdown Data by Type
    • 7.3 European Union Cancer (Tumor) Profiling Breakdown Data by Application

    8 China

    • 8.1 China Cancer (Tumor) Profiling Breakdown Data by Company
    • 8.2 China Cancer (Tumor) Profiling Breakdown Data by Type
    • 8.3 China Cancer (Tumor) Profiling Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Cancer (Tumor) Profiling Breakdown Data by Company
    • 9.2 Rest of World Cancer (Tumor) Profiling Breakdown Data by Type
    • 9.3 Rest of World Cancer (Tumor) Profiling Breakdown Data by Application
    • 9.4 Rest of World Cancer (Tumor) Profiling Breakdown Data by Countries
      • 9.4.1 Rest of World Cancer (Tumor) Profiling Sales by Countries
      • 9.4.2 Rest of World Cancer (Tumor) Profiling Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 Illumina
      • 10.1.1 Illumina Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Cancer (Tumor) Profiling
      • 10.1.4 Cancer (Tumor) Profiling Product Introduction
      • 10.1.5 Illumina Recent Development
    • 10.2 Qiagen
      • 10.2.1 Qiagen Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Cancer (Tumor) Profiling
      • 10.2.4 Cancer (Tumor) Profiling Product Introduction
      • 10.2.5 Qiagen Recent Development
    • 10.3 Neogenomics Laboratories
      • 10.3.1 Neogenomics Laboratories Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Cancer (Tumor) Profiling
      • 10.3.4 Cancer (Tumor) Profiling Product Introduction
      • 10.3.5 Neogenomics Laboratories Recent Development
    • 10.4 HTG Molecular Diagnostics
      • 10.4.1 HTG Molecular Diagnostics Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Cancer (Tumor) Profiling
      • 10.4.4 Cancer (Tumor) Profiling Product Introduction
      • 10.4.5 HTG Molecular Diagnostics Recent Development
    • 10.5 Genomic Health
      • 10.5.1 Genomic Health Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Cancer (Tumor) Profiling
      • 10.5.4 Cancer (Tumor) Profiling Product Introduction
      • 10.5.5 Genomic Health Recent Development
    • 10.6 Caris Life Sciences
      • 10.6.1 Caris Life Sciences Company Details
      • 10.6.2 Company Description and Business Overview
      • 10.6.3 Sales, Revenue and Market Share of Cancer (Tumor) Profiling
      • 10.6.4 Cancer (Tumor) Profiling Product Introduction
      • 10.6.5 Caris Life Sciences Recent Development
    • 10.7 Helomics Corporation
      • 10.7.1 Helomics Corporation Company Details
      • 10.7.2 Company Description and Business Overview
      • 10.7.3 Sales, Revenue and Market Share of Cancer (Tumor) Profiling
      • 10.7.4 Cancer (Tumor) Profiling Product Introduction
      • 10.7.5 Helomics Corporation Recent Development
    • 10.8 Nanostring Technologies
      • 10.8.1 Nanostring Technologies Company Details
      • 10.8.2 Company Description and Business Overview
      • 10.8.3 Sales, Revenue and Market Share of Cancer (Tumor) Profiling
      • 10.8.4 Cancer (Tumor) Profiling Product Introduction
      • 10.8.5 Nanostring Technologies Recent Development
    • 10.9 Oxford Gene Technology
      • 10.9.1 Oxford Gene Technology Company Details
      • 10.9.2 Company Description and Business Overview
      • 10.9.3 Sales, Revenue and Market Share of Cancer (Tumor) Profiling
      • 10.9.4 Cancer (Tumor) Profiling Product Introduction
      • 10.9.5 Oxford Gene Technology Recent Development
    • 10.10 Ribomed Biotechnologies
      • 10.10.1 Ribomed Biotechnologies Company Details
      • 10.10.2 Company Description and Business Overview
      • 10.10.3 Sales, Revenue and Market Share of Cancer (Tumor) Profiling
      • 10.10.4 Cancer (Tumor) Profiling Product Introduction
      • 10.10.5 Ribomed Biotechnologies Recent Development

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Cancer (Tumor) Profiling Sales Channels
      • 11.2.2 Cancer (Tumor) Profiling Distributors
    • 11.3 Cancer (Tumor) Profiling Customers

    12 Market Forecast

    • 12.1 Global Cancer (Tumor) Profiling Sales and Revenue Forecast 2019-2025
    • 12.2 Global Cancer (Tumor) Profiling Sales Forecast by Type
    • 12.3 Global Cancer (Tumor) Profiling Sales Forecast by Application
    • 12.4 Cancer (Tumor) Profiling Forecast by Regions
      • 12.4.1 Global Cancer (Tumor) Profiling Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Cancer (Tumor) Profiling Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      The cancer/tumor profiling market in terms of technology has been segmented into next generation sequencing (NGS), quantitative polymerase chain reaction (QPCR), immunohistochemistry (IHC), in-situ hybridization (ISH), and microarray, based on technology.
      Europe held the second largest share of 27.7% in the global cancer/tumor profiling market in 2017.
      In 2019, the market size of Cancer (Tumor) Profiling is 5260 million US$ and it will reach 12100 million US$ in 2025, growing at a CAGR of 11.0% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Cancer (Tumor) Profiling.

      This report studies the global market size of Cancer (Tumor) Profiling, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Cancer (Tumor) Profiling sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      Illumina
      Qiagen
      Neogenomics Laboratories
      HTG Molecular Diagnostics
      Genomic Health
      Caris Life Sciences
      Helomics Corporation
      Nanostring Technologies
      Oxford Gene Technology
      Ribomed Biotechnologies

      Market Segment by Product Type
      Immunoassay
      Hybridization
      NGS
      Mass Spectrometry

      Market Segment by Application
      Clinical
      Research

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Cancer (Tumor) Profiling status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Cancer (Tumor) Profiling manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Cancer (Tumor) Profiling are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now